101 related articles for article (PubMed ID: 8640945)
1. The antitumor drug fostriecin induces vimentin hyperphosphorylation and intermediate filament reorganization.
Ho DT; Roberge M
Carcinogenesis; 1996 May; 17(5):967-72. PubMed ID: 8640945
[TBL] [Abstract][Full Text] [Related]
2. Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation.
Guo XW; Th'ng JP; Swank RA; Anderson HJ; Tudan C; Bradbury EM; Roberge M
EMBO J; 1995 Mar; 14(5):976-85. PubMed ID: 7889943
[TBL] [Abstract][Full Text] [Related]
3. Taxol induces concomitant hyperphosphorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells.
Chu JJ; Chen KD; Lin YL; Fei CY; Chiang AS; Chiang CD; Lai YK
J Cell Biochem; 1998 Mar; 68(4):472-83. PubMed ID: 9493910
[TBL] [Abstract][Full Text] [Related]
4. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A.
Roberge M; Tudan C; Hung SM; Harder KW; Jirik FR; Anderson H
Cancer Res; 1994 Dec; 54(23):6115-21. PubMed ID: 7954457
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle-dependent changes in the organization of an intermediate filament-associated protein: correlation with phosphorylation by p34cdc2.
Skalli O; Chou YH; Goldman RD
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11959-63. PubMed ID: 1281546
[TBL] [Abstract][Full Text] [Related]
6. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.
Walsh AH; Cheng A; Honkanen RE
FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158
[TBL] [Abstract][Full Text] [Related]
7. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
[TBL] [Abstract][Full Text] [Related]
8. Reversible hyperphosphorylation and reorganization of vimentin intermediate filaments by okadaic acid in 9L rat brain tumor cells.
Lee WC; Yu JS; Yang SD; Lai YK
J Cell Biochem; 1992 Aug; 49(4):378-93. PubMed ID: 1331124
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphorylation in keratin and vimentin filament integrity in cultured thyroid epithelial cells.
Deery WJ
Cell Motil Cytoskeleton; 1993; 26(4):325-39. PubMed ID: 7507800
[TBL] [Abstract][Full Text] [Related]
10. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments.
Eriksson JE; He T; Trejo-Skalli AV; Härmälä-Braskén AS; Hellman J; Chou YH; Goldman RD
J Cell Sci; 2004 Feb; 117(Pt 6):919-32. PubMed ID: 14762106
[TBL] [Abstract][Full Text] [Related]
11. Association of protein phosphatase 2A with its substrate vimentin intermediate filaments in 9L rat brain tumor cells.
Cheng TJ; Lin YL; Chiang AS; Lai YK
J Cell Biochem; 2000 Jul; 79(1):126-38. PubMed ID: 10906761
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia.
Armstrong SC; Gao W; Lane JR; Ganote CE
J Mol Cell Cardiol; 1998 Jan; 30(1):61-73. PubMed ID: 9500865
[TBL] [Abstract][Full Text] [Related]
13. The relative roles of specific N- and C-terminal phosphorylation sites in the disassembly of intermediate filament in mitotic BHK-21 cells.
Chou YH; Opal P; Quinlan RA; Goldman RD
J Cell Sci; 1996 Apr; 109 ( Pt 4)():817-26. PubMed ID: 8718673
[TBL] [Abstract][Full Text] [Related]
14. A novel taxol-induced vimentin phosphorylation and stabilization revealed by studies on stable microtubules and vimentin intermediate filaments.
Vilalta PM; Zhang L; Hamm-Alvarez SF
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1841-52. PubMed ID: 9625747
[TBL] [Abstract][Full Text] [Related]
15. The regulation of intermediate filament reorganization in mitosis. p34cdc2 phosphorylates vimentin at a unique N-terminal site.
Chou YH; Ngai KL; Goldman R
J Biol Chem; 1991 Apr; 266(12):7325-8. PubMed ID: 2019567
[TBL] [Abstract][Full Text] [Related]
16. Fostriecin: a review of the preclinical data.
de Jong RS; de Vries EG; Mulder NH
Anticancer Drugs; 1997 Jun; 8(5):413-8. PubMed ID: 9215602
[TBL] [Abstract][Full Text] [Related]
17. Intermediate filament reorganization during mitosis is mediated by p34cdc2 phosphorylation of vimentin.
Chou YH; Bischoff JR; Beach D; Goldman RD
Cell; 1990 Sep; 62(6):1063-71. PubMed ID: 2169348
[TBL] [Abstract][Full Text] [Related]
18. PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells.
Benítez-King G
J Pineal Res; 2000 Aug; 29(1):8-14. PubMed ID: 10949535
[TBL] [Abstract][Full Text] [Related]
19. Fostriecin: chemistry and biology.
Lewy DS; Gauss CM; Soenen DR; Boger DL
Curr Med Chem; 2002 Nov; 9(22):2005-32. PubMed ID: 12369868
[TBL] [Abstract][Full Text] [Related]
20. Induction of aggregation and augmentation of protein kinase-mediated phosphorylation of purified vimentin intermediate filaments by withangulatin A.
Perng MD; Cheng TJ; Chen CM; Lai YK
Mol Pharmacol; 1994 Oct; 46(4):612-7. PubMed ID: 7969040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
